News
SERENA-6 Trial: ctDNA-Guided Camizestrant Switch Redefines 1st-Line Advanced Breast Cancer Treatment
The phase 3 SERENA-6 trial shows that ctDNA-guided early treatment switch to camizestrant plus a CDK4/6 inhibitor in HR+, ...
A Paradigm Shift: World-First Clinical Trial Confirms Exercise Boosts Survival Rates in Colon Cancer
A Canadian Cancer Society-funded trial shows a 3-year structured exercise program post-chemotherapy improves survival for colon cancer patients. Involving 889 participants, the trial saw a 28% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback